Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Sevelamer Carbonate Tablets, 800 mg, from the USFDA
Intensity Therapeutics, Inc., a biotechnology firm, declares that the organization executed an alliance with The Swiss Group for Clinical Cancer Research (SAKK) to lead a stage 2 randomized (coordinated), controlled preliminary assessing clinical...
Mabwell Therapeutics, a biotechnology firm, reported that its self-created novel Nectin-4-focusing on ADC (Research and development code: 9MW2821) has been conceded Orphan Drug Designation (ODD) by the US FDA, for the therapy of esophageal...
Cipla, a renowned global pharmaceutical company, reported a high consolidated net profit growth of 79% to Rs. 932 crore in the fourth quarter ended March 2024, compared to Rs. 522 crore in the same time last year. Its earnings before tax and...
Keenness Drugs, Inc., a clinical-stage biopharmaceutical organization fostering a novel therapeutic that objectives harmful solvent amyloid beta oligomers (AßOs) for the treatment of Alzheimer's disease (AD), declared that the main patient has...
.jpg)
Recce Drugs Ltd, an organization growing a new class of synthetic anti-infectives intended to address the pressing worldwide medical conditions of anti-resistant safe superbugs and arising viral microbes, declared the China National Intellectual...
Arbor Biotechnologies, Inc., a biotechnology organization that finds and fosters the next generation of hereditary prescriptions, has reported the acquisition of Serendipity Biosciences, a confidential organization focused on the revelation of...
Caring Cross, a non-benefit devoted to speeding up the improvement of cutting edge prescriptions and empowering admittance to solutions for all patients, all over the place, and ImmunoAdoptive Cell Therapy (ImmunoACT), a cell and gene therapy...
Cellipont Bioservices, a pharmaceutical company and Adva Biotechnology, an Israel-based private biotechnology organization giving a decentralized, robotized, and productive assembling stage for cutting-edge cell treatments, reported its alliance...
Sobi reported that the European Commission (EC) has sanctioned a sign augmentation for Aspaveli (pegcetacoplan) for treatment of grown-up patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Aspaveli is as of...
, CDSCO.jpg)
.jpg)